کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9989748 | 1580764 | 2005 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
علم عصب شناسی
عصب شناسی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Amyotrophic lateral sclerosis (ALS) is fatal disorder, characterized by the loss of motoneurons. The therapeutic potential of transforming growth factor-beta 2 (TGF-β2) was examined using SOD1 mice. The SOD1 mice were treated with TGF-β2 by repeated intraperitoneal injections. The highest dose of TGF-β2 caused a rapid and marked improvement in the motor performance of the mice. This improvement lasted for between 2 and 3 weeks after which the TGF-β2-treated mice rapidly deteriorated. At postmortem, the motoneurons in the TGF-β2-treated SOD1 mice exhibited a large hypertrophy of their nucleoli, nuclei, and axons. In contrast, TGF-β2 did not reverse the mitochondrial pathology. This may explain why the beneficial effects of TGF-β2 and other growth factor on SOD1 mice are transient: TGF-β2 is stimulating the motoneurons metabolic rate while one of their key metabolic organelles is damaged. Consequently, TGF-β2 may be therapeutic for the forms ALS, with minimal mitochondrial involvement.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neurobiology of Disease - Volume 19, Issues 1â2, JuneâJuly 2005, Pages 323-330
Journal: Neurobiology of Disease - Volume 19, Issues 1â2, JuneâJuly 2005, Pages 323-330
نویسندگان
W. Antony Day, Kyoko Koishi, Hitoshi Nukuda, Ian S. McLennan,